Favorable preliminary safety profile of NVL-520 suggests potential for a highly ROS1-selective, TRK sparing design, with no dose-limiting toxicities, treatment-related serious adverse events, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results